Scimago Journal & Country Rank

Frontiers in Clinical Drug Research - Anti Infectives

Country

Netherlands

Universities and research institutions in Netherlands
Media Ranking in Netherlands

Subject Area and Category

Publisher

Bentham Science Publishers B.V.

H-Index

2

Publication type

Book Series

ISSN

23523212, 24523208

Coverage

2019-2021

Information

Homepage

Scope

Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology. Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Drug Discovery2020Q4
Drug Discovery2021Q3
Drug Discovery2022Q4
Drug Discovery2023Q4
Infectious Diseases2020Q4
Infectious Diseases2021Q3
Infectious Diseases2022Q4
Infectious Diseases2023Q4
Pharmacology2020Q4
Pharmacology2021Q3
Pharmacology2022Q4
Pharmacology2023Q4
Pharmacology (medical)2020Q3
Pharmacology (medical)2021Q3
Pharmacology (medical)2022Q4
Pharmacology (medical)2023Q4
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20200.205
20210.359
20220.149
20230.104
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
20197
20207
202113
20220
20230
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20190.000
Cites / Doc. (4 years)20200.571
Cites / Doc. (4 years)20210.571
Cites / Doc. (4 years)20220.481
Cites / Doc. (4 years)20230.407
Cites / Doc. (3 years)20190.000
Cites / Doc. (3 years)20200.571
Cites / Doc. (3 years)20210.571
Cites / Doc. (3 years)20220.481
Cites / Doc. (3 years)20230.050
Cites / Doc. (2 years)20190.000
Cites / Doc. (2 years)20200.571
Cites / Doc. (2 years)20210.571
Cites / Doc. (2 years)20220.150
Cites / Doc. (2 years)20230.000
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20190
Self Cites20200
Self Cites20210
Self Cites20220
Self Cites20230
Total Cites20190
Total Cites20204
Total Cites20218
Total Cites202213
Total Cites20231
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20190
External Cites per document20200.571
External Cites per document20210.571
External Cites per document20220.481
External Cites per document20230.050
Cites per document20190.000
Cites per document20200.571
Cites per document20210.571
Cites per document20220.481
Cites per document20230.050
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
201914.29
202014.29
20217.69
20220
20230
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20190
Non-citable documents20205
Non-citable documents202112
Non-citable documents202216
Non-citable documents202311
Citable documents20190
Citable documents20202
Citable documents20212
Citable documents202211
Citable documents20239
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20190
Uncited documents20205
Uncited documents202112
Uncited documents202222
Uncited documents202319
Cited documents20190
Cited documents20202
Cited documents20212
Cited documents20225
Cited documents20231
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of March 2024
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2024. Data Source: Scopus®

Legal Notice

Privacy Policy